Abstract Background and Aims Bacterial species and microbial pathways along with
metabolites and clinical parameters may interact to contribute to non‐alcoholic fatty liver …

Non-alcoholic fatty liver disease (NAFLD) is currently related to a heavy socioeconomic
burden and increased incidence. Since obesity is the most prevalent risk factor for NAFLD …

The prevalence of non-alcoholic fatty liver disease (NAFLD) is increasing, as are other
manifestations of metabolic syndrome such as obesity and type 2 diabetes. NAFLD is …

This study aimed to determine if there is an association between dysbiosis and nonalcoholic
fatty liver disease (NAFLD) independent of obesity and insulin resistance (IR). This is a …

Increasing evidence suggests a role of intestinal dysbiosis in obesity and non-alcoholic fatty
liver disease (NAFLD). But it remains unknown in nonobese NAFLD. This prospective, cross …

Several animal studies have emphasized the role of gut microbiota in nonalcoholic fatty liver
disease (NAFLD). However, data about gut dysbiosis in human NAFLD remain scarce in the …

Methods Gut microbiome profiles of 40 NAFLD and 20 non-NAFLD controls were analyzed.
Information about four blood lipids and 13 other clinical features was collected. Patients …

To evaluate the changes in the gut microbiota associated with changes in the biochemical
markers of nonalcoholic fatty liver disease (NAFLD) after a lifestyle intervention with the …

Abstract Background and Aim Non‐alcoholic fatty liver disease (NAFLD) is the most
common cause of liver disease. Increasing evidence indicates that the gut microbiota can …

Background/aim Alterations in gut microbiota are associated with the pathogenesis of
metabolic diseases, including metabolic-associated fatty liver disease (MAFLD). The aim of …